Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

Aromatase gene variation may increase female hair loss risk.

Women with PCOS have a higher risk of heart disease.

Anorexia and bulimia lead to serious health problems and increased risk of death, requiring aggressive treatment.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Finasteride helps improve hair growth in men with hair loss but may increase the risk of erectile dysfunction.

Less attractive male venture capitalists take more risks influenced by entrepreneurs' looks, while more attractive ones are generally risk-tolerant.

People with alopecia areata have a higher risk of heart disease.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Common skin conditions can greatly affect a person's mental health and social life.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

PCOS skin symptoms need personalized treatment and psychological support to improve quality of life.

Social media doesn't significantly influence treatment choices for hair loss, but better education on options is needed.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

PRP treatment may help with alopecia areata, especially in newer cases.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Alopecia areata significantly worsens quality of life in children, causing embarrassment and social issues.

The questionnaire is valid and reliable but needs more testing for future predictions.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.